Talk:Arcuate nucleus
Discussion page·2 threads·no archives
This is the discussion page for the article Arcuate nucleus. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.
Inverse agonism at MC4RResolved
AgRP is usually described as an antagonist. Calling it an inverse agonist is more accurate but will look like an error to readers who learned it the other way. Worth the half-sentence of explanation the article gives. — MelanocortinMil (talk) 10:15, 28 February 2026 (UTC)
Agreed — the explanation is what makes the distinction useful rather than pedantic, since constitutive activity is why the receptor matters clinically. ✓ Done — ArcuateArt (talk) 13:50, 28 February 2026 (UTC)
How much animal work should be cited as though it were human?
Several statements here rest on rodent studies. The article says so in one place. It should probably say so in each. — PrimarySrcPatia (talk) 11:40, 14 April 2026 (UTC)
I have added "in animal models" to the POMC-activation sentence and kept the general statement that human contributions are inferred rather than measured. Repeating it in every sentence would be unreadable. — ArcuateArt (talk) 15:25, 14 April 2026 (UTC)
That is a reasonable balance — one explicit statement of provenance plus a marker on the strongest claim. — PrimarySrcPatia (talk) 09:00, 15 April 2026 (UTC)